DINUTUXIMAB BETA: 157 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
157
Total FAERS Reports
30 (19.1%)
Deaths Reported
24
Hospitalizations
157
As Primary/Secondary Suspect
9
Life-Threatening
3
Disabilities
First Report: 201701 · Latest Report: 20250903
What Are the Most Common DINUTUXIMAB BETA Side Effects?
#1 Most Reported
Off label use
82 reports (52.2%)
#2 Most Reported
Pyrexia
57 reports (36.3%)
#3 Most Reported
Pain
46 reports (29.3%)
All DINUTUXIMAB BETA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 82 | 52.2% | 22 | 7 |
| Pyrexia | 57 | 36.3% | 2 | 7 |
| Pain | 46 | 29.3% | 3 | 3 |
| Death | 20 | 12.7% | 20 | 0 |
| Neoplasm progression | 20 | 12.7% | 14 | 0 |
| Device related bacteraemia | 17 | 10.8% | 0 | 0 |
| Device related infection | 16 | 10.2% | 0 | 0 |
| Diarrhoea | 11 | 7.0% | 1 | 1 |
| Therapy partial responder | 11 | 7.0% | 6 | 0 |
| Cough | 10 | 6.4% | 0 | 0 |
| Rash | 10 | 6.4% | 1 | 0 |
| Cholestasis | 7 | 4.5% | 0 | 7 |
| Pruritus | 7 | 4.5% | 1 | 0 |
| Acute myeloid leukaemia | 6 | 3.8% | 0 | 0 |
| Alanine aminotransferase abnormal | 6 | 3.8% | 0 | 0 |
| Anaemia | 6 | 3.8% | 1 | 1 |
| Aspartate aminotransferase abnormal | 6 | 3.8% | 0 | 0 |
| Capillary leak syndrome | 6 | 3.8% | 1 | 0 |
| Chills | 6 | 3.8% | 0 | 0 |
| Hypoglycaemia | 6 | 3.8% | 0 | 0 |
Who Reports DINUTUXIMAB BETA Side Effects? Age & Gender Data
Gender: 49.2% female, 50.8% male. Average age: 5.5 years. Most reports from: FR. View detailed demographics →
Is DINUTUXIMAB BETA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 4 | 0 | 0 |
| 2019 | 6 | 0 | 4 |
| 2020 | 5 | 1 | 1 |
| 2021 | 6 | 2 | 5 |
| 2022 | 8 | 1 | 3 |
| 2023 | 15 | 0 | 5 |
| 2024 | 13 | 0 | 3 |
| 2025 | 1 | 0 | 1 |
What Is DINUTUXIMAB BETA Used For?
| Indication | Reports |
|---|---|
| Neuroblastoma | 141 |
| Metastases to bone marrow | 27 |
| Bone cancer metastatic | 26 |
| Neuroblastoma recurrent | 13 |
| Metastatic lymphoma | 7 |
DINUTUXIMAB BETA vs Alternatives: Which Is Safer?
DINUTUXIMAB BETA vs DIOSMIN
DINUTUXIMAB BETA vs DIOSMIN\HESPERIDIN
DINUTUXIMAB BETA vs DIOVAN
DINUTUXIMAB BETA vs DIPHENHYDRAMINE
DINUTUXIMAB BETA vs DIPHENHYDRAMINE\IBUPROFEN
DINUTUXIMAB BETA vs DIPHENHYDRAMINE\NAPROXEN
DINUTUXIMAB BETA vs DIPHENOXYLATE
DINUTUXIMAB BETA vs DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED AND INACTIVATED POLIOVIRUS VACCINE
DINUTUXIMAB BETA vs DIPYRIDAMOLE
DINUTUXIMAB BETA vs DIPYRONE
Official FDA Label for DINUTUXIMAB BETA
Official prescribing information from the FDA-approved drug label.